|
US5594001A
(en)
*
|
1993-04-08 |
1997-01-14 |
The Dupont Merck Pharmaceutical Company |
Polycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disorders
|
|
BR9405954A
(pt)
*
|
1993-04-08 |
1995-12-26 |
Du Pont Merck Pharma |
Compostos policíclicos e derivados dos mesmos composições farmacêuticas e método de tratamento de disfunção cognitiva ou neurológica
|
|
IL112248A0
(en)
|
1994-01-25 |
1995-03-30 |
Warner Lambert Co |
Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
|
|
US5654307A
(en)
|
1994-01-25 |
1997-08-05 |
Warner-Lambert Company |
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
|
|
AU2001231154A1
(en)
|
2000-01-24 |
2001-07-31 |
Adherex Technologies Inc. |
Peptidomimetic modulators of cell adhesion
|
|
US6608053B2
(en)
|
2000-04-27 |
2003-08-19 |
Yamanouchi Pharmaceutical Co., Ltd. |
Fused heteroaryl derivatives
|
|
US20020123485A1
(en)
|
2000-07-27 |
2002-09-05 |
Alexander John C. |
Epoxy steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure
|
|
US7291733B2
(en)
*
|
2003-10-10 |
2007-11-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted tricyclic heterocycles and their uses
|
|
US20090099165A1
(en)
|
2003-10-14 |
2009-04-16 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Protein Kinase Inhibitors
|
|
ES2344007T3
(es)
|
2003-10-14 |
2010-08-16 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Inhibidores proteina quinasa.
|
|
AR049300A1
(es)
|
2004-06-15 |
2006-07-12 |
Schering Corp |
Compuestos triciclicos antagonistas de mglur1 como agentes terapeuticos
|
|
EP1619196A1
(de)
|
2004-07-23 |
2006-01-25 |
Curacyte Discovery GmbH |
Substituierte Pyrido[3',2':4,5]thieno[3,2-d]pyrimidine und Pyrido[3',2':4,5]furo[3,2-d]-pyrimidine zur Verwendung als Inhibitoren der PDA-4 und/oder TNF-alpha Freisetzung
|
|
WO2006010567A1
(de)
|
2004-07-23 |
2006-02-02 |
Curacyte Discovery Gmbh |
INHIBITOREN DER PHOSPHODIESTERASE 4 UND TNFα-FREISETZUNG
|
|
MX2007004794A
(es)
*
|
2004-10-25 |
2007-07-09 |
Lilly Co Eli |
Tienopiridinas como potenciadores alostericos del receptor muscarinico m4.
|
|
ES2259892B1
(es)
|
2004-11-30 |
2007-11-01 |
Laboratorios Almirall S.A. |
Nuevos derivados de piridotienopirimidina.
|
|
ES2259891B1
(es)
|
2004-11-30 |
2007-11-01 |
Laboratorios Almirall S.A. |
Nuevos derivados de piridotienopirimidina.
|
|
MX2007007026A
(es)
*
|
2004-12-17 |
2007-07-04 |
Hoffmann La Roche |
Derivados de tieno-piridina como intensificadores alostericos de gaba-b.
|
|
WO2006138418A2
(en)
|
2005-06-14 |
2006-12-28 |
President And Fellows Of Harvard College |
Improvement of cognitive performance with sirtuin activators
|
|
AR059901A1
(es)
|
2006-03-20 |
2008-05-07 |
Bayer Pharmaceuticals Corp |
Compuestos de tetrahidropiridotienopirimidina utiles para tratar o prevenir trastornos proliferativos celulares.
|
|
EP2038289A2
(en)
*
|
2006-04-21 |
2009-03-25 |
Amgen Inc. |
Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of use
|
|
US20080021063A1
(en)
|
2006-07-18 |
2008-01-24 |
Kazantsev Aleksey G |
Compositions and methods for modulating sirtuin activity
|
|
US7547781B2
(en)
|
2006-09-11 |
2009-06-16 |
Curis, Inc. |
Quinazoline based EGFR inhibitors containing a zinc binding moiety
|
|
JP2010514810A
(ja)
|
2006-12-29 |
2010-05-06 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
Ａｘｌインヒビターとして有用な置換トリアゾール
|
|
US20090105240A1
(en)
|
2007-10-17 |
2009-04-23 |
Tomas Mustelin |
Methods for treating leukemia and myelodysplastic syndrome, and methods for identifying agents for treating same
|
|
WO2009151569A2
(en)
|
2008-06-09 |
2009-12-17 |
Combinatorx, Incorporated |
Beta adrenergic receptor agonists for the treatment of b-cell proliferative disorders
|
|
AU2010286168B2
(en)
|
2009-08-20 |
2014-05-15 |
Karus Therapeutics Limited |
Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
|
|
US20110178107A1
(en)
|
2010-01-20 |
2011-07-21 |
Taigen Biotechnology Co., Ltd. |
Hcv protease inhibitors
|
|
WO2012131297A1
(en)
*
|
2011-03-28 |
2012-10-04 |
Jonathan Bayldon Baell |
Pyrido [3',2' :4,5] thieno [3, 2-d] pyrimidin- 4 - ylamine derivatives and their therapeutical use
|
|
US9056876B2
(en)
*
|
2011-09-16 |
2015-06-16 |
Vanderbilt University |
Substituted 1H-pyrazolo[3′,4′,4,5]thieno[2,3-b]pyridin-3-amine analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4
|
|
US20130116241A1
(en)
|
2011-11-09 |
2013-05-09 |
Abbvie Inc. |
Novel inhibitor compounds of phosphodiesterase type 10a
|
|
US9353121B2
(en)
|
2011-12-21 |
2016-05-31 |
The Regents Of The University Of Colorado, A Body Corporate |
Anti-cancer compounds targeting Ral GTPases and methods of using the same
|
|
US8697888B2
(en)
|
2012-01-06 |
2014-04-15 |
Vanderbilt University |
Substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs as antagonists of muscarinic acetylcholine M1 receptors
|
|
WO2013126856A1
(en)
|
2012-02-23 |
2013-08-29 |
Vanderbilt University |
Substituted 5-aminothieno[2,3-c]pyridazine-6-carboxamide analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m4
|
|
HK1210696A1
(en)
|
2012-07-11 |
2016-05-06 |
Nimbus Iris, Inc. |
Irak inhibitors and uses thereof
|
|
US9056875B2
(en)
|
2012-08-31 |
2015-06-16 |
Vanderbilt University |
Substituted pyrazolo[3′,4′:4,5]thieno[2,3-C]pyridazin-3-amine analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4
|
|
WO2015027204A1
(en)
|
2013-08-23 |
2015-02-26 |
Vanderbilt University |
Substituted thieno[2,3-b]pyridine-2-carboxamide analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m4
|
|
US9637498B2
(en)
|
2013-08-23 |
2017-05-02 |
Vanderbilt University |
Substituted thieno[2,3-C]pyridazine-6-carboxamide analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4
|
|
US9981920B2
(en)
|
2014-06-26 |
2018-05-29 |
Rodin Therapeutics, Inc. |
Inhibitors of histone deacetylase
|
|
BR112018003417B1
(pt)
|
2016-06-22 |
2023-10-24 |
Vanderbilt University |
Composto modulador alostérico positivo do receptor muscarínico de acetilcolina m4 e composição farmacêutica que o compreende
|
|
CN109862893B
(zh)
|
2016-11-07 |
2023-02-17 |
范德比尔特大学 |
毒蕈碱型乙酰胆碱受体m4的正向别构调节剂
|
|
US11008335B2
(en)
|
2016-11-07 |
2021-05-18 |
Vanderbilt University |
Positive allosteric modulators of the muscarinic acetylcholine receptor M4
|